Navigation Links
Smithsonian researchers find differences between Galapagos and mainland frigatebirds
Date:9/28/2010

Although the magnificent frigatebird may be the least likely animal on the Galapagos Islands to be unique to the area, it turns out the Galapagos population of this tropical seabird may be its own genetically distinct species warranting a new conservation status, according to a paper by researchers at the Smithsonian Conservation Biology Institute, the Smithsonian's National Museum of Natural History and the University of Missouri-St. Louis published last week in the scientific journal Proceedings of the Royal Society B.

The Galapagos Islands, which once served as a scientific laboratory for Charles Darwin, boast a number of unique plant and animal species, from tortoises to iguanas to penguins. Magnificent frigatebirds, however, can fly hundreds of kilometers across open ocean, suggesting that their gene flow should be widespread and their genetic make-up should be identical to those of the magnificent frigatebirds on the mainland coast of the Americas. Even Darwin predicted that most Galapagos seabirds would not be very different from their mainland counterparts. But researchers at SCBI conducted three different kinds of genetics tests and all yielded the same resultthe Galapagos seabirds have been genetically different from the magnificent frigatebirds elsewhere for more than half a million years.

"This was such a surprise," said Frank Hailer, a postdoctoral research associate at SCBI and lead author of the paper. "It's a great testimony to just how unique the fauna and flora of the Galapagos are. Even something that is so well-adapted to flying over open oceans is isolated there."

Scientists began the research to determine whether the magnificent frigatebird on the Galapagos was more similar genetically to the magnificent frigatebirds on the Caribbean side or the Pacific side of the islands. Using frigatebird samples from Betty Anne Schreiber at the National Museum of Natural History, Iris Levin and Patricia Parker at the
'/>"/>

Contact: Lindsay Renick Mayer
renickmayerl@si.edu
202-633-3081
Smithsonian
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Smithsonian scientists help create first frozen repository for Hawaiian coral
2. Smithsonian hosts 2010 International CAM Workshop in Panama
3. Stress and trade-offs explain lifes diversity: New Smithsonian model
4. Smithsonian scientists find the frog legs trade may facilitate spread of pathogens
5. First jaguar photo taken at Smithsonian Research Station in Panama
6. Smithsonian scientist warns that palm oil development may threaten Amazon
7. Smithsonian scientists receive coveted BBVA Ecology and Conservation Award
8. New movement models tested at the Smithsonian in Panama
9. Smithsonian puts tropical eastern Pacific shore fishes online
10. Smithsonian puts tropical Eastern-Pacific shore fishes online
11. Smithsonian perspective: Biodiversity in a warmer world
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Smithsonian researchers find differences between Galapagos and mainland frigatebirds
(Date:9/2/2014)... Yale Cancer Center researchers may have discovered a ... cells made vulnerable by deficient DNA repair. , The ... Reports . , The study, led by James ... Yale School of Medicine, found that cancer cells with ... their own genetic damage) were significantly more vulnerable to ...
(Date:9/2/2014)... digital distribution of media will have lower carbon ... when file sizes are large. , That,s the ... Journal of Industrial Ecology that looked at ... as PlayStation3. Researchers found that Blu-ray Discs delivered ... than game files downloaded over broadband Internet. For ...
(Date:9/2/2014)... 2, 2014 In a new study that could ... Florida campus of The Scripps Research Institute (TSRI) have ... unique manufacturing sites for molecules that can treat a ... as a reaction vessel and a disease-causing defect as ... cell," said TSRI Professor Matthew Disney.,"Because the treatment is ...
Breaking Biology News(10 mins):Sabotage as therapy: Aiming lupus antibodies at vulnerable cancer cells 2Scripps Florida scientists make diseased cells synthesize their own drug 2
... world,s subspecies of tigers are now extinct. A new study ... a result of human activities, particularly the conversion of natural ... The study, conducted by Virginia Tech and World Wildlife ... investigate the use of different land cover types not ...
... People with schizophrenia who completed 80 hours of intensive, ... complex tasks that required them to distinguish their internal ... Neuron (2/22/12), a small clinical study conducted ... the University of California, San Francisco (UCSF), tested the ...
... Biology Department Chairman Thomas Chiles has been named the ... of Biology, the university announced today. Chiles, whose ... by the National Cancer Institute, the National Institutes of ... receive the endowed professorship, which will support his ongoing ...
Cached Biology News:Nowhere to hide: Study finds future of Sumatran tigers threatened by human disturbances 2Nowhere to hide: Study finds future of Sumatran tigers threatened by human disturbances 3Schizophrenia patients' ability to monitor reality may be helped by computerized training 2Schizophrenia patients' ability to monitor reality may be helped by computerized training 3Boston College names Thomas Chiles the Deluca Professor of Biology 2
(Date:9/2/2014)... critical, yet often overlooked factor in the medical ... effects of aggregation on both radiofrequency heating and ... oxide nanoparticles (IONPs), including detailed analysis of the ... is shown to produce significant reductions in both ... new method to quantify and correlate these effects ...
(Date:9/2/2014)... including University of Oregon chemist Geraldine Richmond, have ... self-assembling, synthetic proteins called peptoid nanosheets that mimic ... -- detailed this week in a paper placed ... of the National Academy of Sciences -- ... the two-dimensional peptoid nanosheets that can be used ...
(Date:9/2/2014)... , Sept. 2, 2014  TransCelerate BioPharma Inc. ... recommended approach for protecting personal data in Clinical ... patients and others. The document describes an approach ... from CSRs and other related clinical trial documents, ... The goal of the TransCelerate CSR Redaction approach ...
(Date:9/2/2014)... Opertech Bio, Inc., a company ... effective approach to sensory evaluation, today announced the ... U.S. Patent and Trademark Office, encompassing high-throughput sensory ... “Opertech’s taste evaluation technology called Microtiter Operant Gustometer ... system for rapid characterization of taste sensory properties,” ...
Breaking Biology Technology:Accounting for biological aggregation in heating and imaging of magnetic nanoparticles 2UO-Berkeley Lab unveil new nano-sized synthetic scaffolding technique 2TransCelerate BioPharma Inc. Releases Recommended Approach for Protecting Personal Data in Clinical Study Reports 2TransCelerate BioPharma Inc. Releases Recommended Approach for Protecting Personal Data in Clinical Study Reports 3Opertech Bio Receives U.S. Patent for High-Throughput Taste Evaluation Technology 2
... Randomized Study Under Consideration, ROCKVILLE, Md., Nov. ... clinical-stage pharmaceutical company developing,therapeutics for the treatment of ... met the primary endpoint for the efficacy portion ... in combination with pemetrexed,(Alimta(R)) in non-small cell lung ...
... update on business and product pipeline, BOTHELL, ... Inc. (NASDAQ: OGXI ), a biopharmaceutical company ... that address,unmet needs in the treatment of cancer, ... and nine months ended September 30, 2008., ...
... 10 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical,Group (NYSE: SCR ... generic,pharmaceuticals and innovative anti-cancer pharmaceuticals in the rapidly,growing ... Morgan,Stanley 7th Annual Asia Pacific Summit 2008. The ... on November 11-13, 2008., Simcere,s chief financial ...
Cached Biology Technology:EntreMed's MKC-1 Meets Primary Efficacy Endpoint in Non-Small Cell Lung Cancer Clinical Trial 2EntreMed's MKC-1 Meets Primary Efficacy Endpoint in Non-Small Cell Lung Cancer Clinical Trial 3OncoGenex Reports Third Quarter Financial Results 2OncoGenex Reports Third Quarter Financial Results 3OncoGenex Reports Third Quarter Financial Results 4OncoGenex Reports Third Quarter Financial Results 5OncoGenex Reports Third Quarter Financial Results 6OncoGenex Reports Third Quarter Financial Results 7OncoGenex Reports Third Quarter Financial Results 8OncoGenex Reports Third Quarter Financial Results 9Simcere Pharmaceutical Group to Participate in Morgan Stanley Seventh Annual Asia Pacific Summit 2008 2
...
solute carrier family 25, member 13 (citrin)...
... Ladder is suitable for sizing ... 16 kb by agarose gel ... be visualized by ethidium bromide ... detected on Southern blots by ...
Immunogen: Recombinant full length protein, corresponding to amino acids 1-435 of Human AP2M1. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: